Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pharmadrug Inc (PHRX.CN)
Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,803
  • Shares Outstanding, K 360,626
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,876 K
  • 60-Month Beta 2.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.22
Trade PHRX.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings 0.00 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0050 unch
on 10/03/23
0.0100 -50.00%
on 10/02/23
unch (unch)
since 09/01/23
3-Month
0.0050 unch
on 10/03/23
0.0100 -50.00%
on 10/02/23
unch (unch)
since 06/30/23
52-Week
0.0050 unch
on 10/03/23
0.0300 -83.33%
on 02/13/23
-0.0200 (-80.00%)
since 10/03/22

Most Recent Stories

More News
PharmaDrug Announces Amendment to Shareholder Meeting Matter

Toronto, Ontario--(Newsfile Corp. - September 19, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that, further to its press release dated September...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Provides Development Update of Cepharanthine (PD-001) for Cancer and Infectious Disease

Toronto, Ontario--(Newsfile Corp. - September 14, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is pleased to provide an update on the development activities of the...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Announces Appointment of CEO and Changes to the Board of Directors

Toronto, Ontario--(Newsfile Corp. - September 6, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today the appointment of Robert J. Steen as Chief Executive...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Announces Strategic Investment in Sairiyo Therapeutics Inc.

Toronto, Ontario--(Newsfile Corp. - July 18, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that it has reached an agreement yesterday with PharmaTher...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Announces Termination of General Security Agreement and Issuance of Common Shares

Toronto, Ontario--(Newsfile Corp. - July 5, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that it has reached an agreement with the holders of $650,000...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Brings On Advisor to Maximize Shareholder Value With Its Underlying Assets

Toronto, Ontario--(Newsfile Corp. - May 23, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is announcing that it has appointed David Posner to its Advisory Committee...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Announces Cease Trade Order

Toronto, Ontario--(Newsfile Corp. - May 8, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is announcing that the Ontario Securities Commission has issued a "failure...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Announces Non-Brokered Offering of $100,000 of Convertible Secured Debentures

Toronto, Ontario--(Newsfile Corp. - April 14, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Collaborates with PharmaTher for Development of DMT Transdermal Patch

PharmaDrug is positioning to become a leader of DMT-based therapeutics for ocular disease and neuropsychiatric conditionsToronto, Ontario--(Newsfile Corp. - February 22, 2023) - PharmaDrug Inc. (CSE: PHRX)...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)
PharmaDrug Announces Plans for First-In-Human Clinical Study with PD-001 (Enteric-Coated Cepharanthine -2HCL) in Esophageal Cancer

Toronto, Ontario--(Newsfile Corp. - February 13, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0048 (-4.00%)
PHRX.CN : 0.0050 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0133
2nd Resistance Point 0.0117
1st Resistance Point 0.0083
Last Price 0.0050
1st Support Level 0.0033
2nd Support Level 0.0017
3rd Support Level N/A

See More

52-Week High 0.0300
Fibonacci 61.8% 0.0204
Fibonacci 50% 0.0175
Fibonacci 38.2% 0.0145
Last Price 0.0050
52-Week Low 0.0050

See More

Business Summary

Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically,...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar